Cite

HARVARD Citation

    Chi, L. et al. (2018). The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease. Inflammatory bowel diseases. 24 (6), pp. 1344-1351. [Online]. 
  
Back to record